The DOI matches its Crossref record.
26274 A dermocosmetic used in combination with the fixed combination adapalene 0.1% and benzoylperoxide 5% helps to protect the skin barrier in mild to moderate acne
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There was a 10.8%-29% mean reduction in TEWL, which was reported to be statistically significant in two studies.
“Further, there was a 10.8%–29% mean reduction in TEWL, which was reported to be statistically significant in two studies.44, 45, 48, 50, 52, 54”
From International expert consensus recommendations for the use of dermocosmetics in acne. (2025) · cites this paper as [45]
In controlled trials, use of dermocosmetics was associated with persistent reduction in visible acne lesions after prescription therapy or maintained acne clearance, with significant differences versus placebo/comparator.
“In the controlled trials, use of dermocosmetics was associated with both a persistent reduction in visible acne lesions after prescription therapy or maintained acne clearance; differences were significant versus placebo/comparator.41, 44, 45”
From International expert consensus recommendations for the use of dermocosmetics in acne. (2025) · cites this paper as [45]
The effects on efficacy and clinical outcomes statistically significantly improved with use of dermocosmetics in three of the RCTs with trends towards better outcomes in the remaining two RCTs.
“The effects on efficacy and clinical outcomes statistically significantly improved with use of dermocosmetics in three of the RCTs with trends towards better outcomes in the remaining two RCTs (Table 3).”
From International expert consensus recommendations for the use of dermocosmetics in acne. (2025) · cites this paper as [45]
Benefits included greater reductions in both inflammatory and non-inflammatory lesions, reduced acne flares, maintenance of effects (with continued lesional decreases) after medical therapy was discontinued and a trend towards clinically relevant better global scores.
“Benefits included greater reductions in both inflammatory and non‐inflammatory lesions, reduced acne flares, maintenance of effects (with continued lesional decreases) after medical therapy was discontinued and a trend towards clinically relevant better global scores.44, 45, 48, 49, 57, 58, 59”
From International expert consensus recommendations for the use of dermocosmetics in acne. (2025) · cites this paper as [45]
Three lower quality studies reported a decrease in superficial skin oiliness ranging from 17% to 47.3%, and all differences between adjunctive dermocosmetics groups and prescription therapy alone were statistically significant in favour of the adjunctive arms.
“Three lower quality reported a decrease in superficial skin oiliness ranging from 17% to 47.3%, and all differences between adjunctive dermocosmetics groups and prescription therapy alone were statistically significant in favour of the adjunctive arms.”
From International expert consensus recommendations for the use of dermocosmetics in acne. (2025) · cites this paper as [45]
The RCTs showed a statistically significant improvement in skin hydration on corneometry and a trend towards reducing sebum (sebumeter) with adjunctive dermocosmetics versus prescription therapy alone.
“As shown in Table 3, the RCTs showed a statistically significant improvement in skin hydration on corneometry and a trend towards reducing sebum (sebumeter) with adjunctive dermocosmetics versus prescription therapy alone.”
From International expert consensus recommendations for the use of dermocosmetics in acne. (2025) · cites this paper as [45]
Patients in the adjunctive treatment groups uniformly had better adherence, reported improvements in quality of life and were well satisfied with their acne treatment.
“The results indicate patients in the adjunctive treatment groups uniformly had better adherence, reported improvements in quality of life and were well satisfied with their acne treatment.”
From International expert consensus recommendations for the use of dermocosmetics in acne. (2025) · cites this paper as [45]
Citations
Cited by
Sorted by citations
International expert consensus recommendations for the use of dermocosmetics in acne.
Thiboutot, D., Layton, A. M., Traore, I., Gontijo, G., Troielli, P., Ju, Q., Kurokawa, I., & Dreno, B. (2025) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20145 · Cited by 32
Metadata
- Authors
- Dréno, B., Khammari, A., & Duhamelle, K.
- Affiliations
- Inserm (FR)
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 85
- Issue
- 3
- Pages
- AB94
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W3193874951
- Cited by
- 1
- References
- 0
- Citations by year
- 2023: 1
- FWCI
- 0.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Academy of Dermatology (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Skin Protection and Aging
- Keywords
- cosmeceuticals, adapalene, fixed-dose combination, skin barrier protection, mild to moderate acne, topical acne treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review